📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Zydus Wellness Q3 FY26 Sales Grow 113.7% to ₹9,633 Mn; Gross Margins Expand 1561 Bps
Zydus Wellness reported a massive 113.7% YoY increase in Q3 FY26 net sales to ₹9,633 million, primarily driven by the integration of the newly acquired Comfort Click and RiteBite businesses. Gross margins saw a significant expansion of 1561 bps to 63.3%, although the company reported a net loss of ₹399 million for the quarter due to high finance costs and amortization related to acquisitions. The company maintains dominant market leadership in core categories, with Sugar Free holding a 96.3% share and Glucon-D at 59.0%. Strategic capital restructuring was completed with a ₹10,000 million fundraise and ₹15,000 million NCD repurchase to optimize the balance sheet.
Key Highlights
Net Sales for Q3 FY26 surged 113.7% YoY to ₹9,633 million, while YTD FY26 sales grew 38.4% to ₹24,639 million.
Gross Margin expanded to 63.3% in Q3 FY26, up from 47.7% in the previous year, supported by new high-margin brands.
Sugar Free remains the market leader with a 96.3% share, while Everyuth Peel-off and Scrub hold 76.0% and 48.5% shares respectively.
EBITDA for Q3 FY26 grew by 312.2% YoY to ₹610 million, despite bottom-line pressure from ₹371 million in finance costs.
Completed acquisition of Comfort Click Limited, adding international brands like WeightWorld and maxmedix to the portfolio.
💼 Action for Investors
Investors should focus on the company's ability to transition the high revenue growth into net profitability as acquisition-related interest and amortization costs stabilize. The strong market share in core brands provides a solid foundation, but the performance of the international VMS segment will be the primary driver for future re-rating.
Zydus Wellness Q3 FY26 Net Sales Surge 113.7% Driven by Comfort Click Acquisition
Zydus Wellness reported a massive 113.7% YoY increase in net sales for Q3 FY26, primarily fueled by the integration of the Comfort Click acquisition. While the company reported a net loss of INR 399 million due to high amortization and interest costs from the acquisition, EBITDA grew by 312.2% to INR 610 million. Gross margins expanded significantly to 63% as the new business operates at higher margins, with management targeting 66-67% on an annualized basis. The RiteBite business also showed strong momentum, doubling its legacy performance and nearing double-digit EBITDA margins.
Key Highlights
Net sales grew 113.7% YoY, with the Food & Nutrition segment surging 134%
EBITDA increased by 312.2% YoY to INR 610 million, with margins expanding to 6.3%
Gross margins reached 63% due to the high-margin Comfort Click portfolio mix
Reported a net loss of INR 399 million after accounting for INR 472 million in brand amortization and INR 371 million in interest
RiteBite Max Protein business doubled its legacy performance and is approaching double-digit margins
💼 Action for Investors
Investors should focus on the strong operational growth and margin expansion post-acquisition, while monitoring the deleveraging process and the impact of non-cash amortization on reported profits.
Zydus Wellness Q3 FY26 Net Sales Surge 113.7% to Rs 9,633 Mn; EBITDA Jumps 312%
Zydus Wellness reported a massive 113.7% year-on-year growth in net sales for Q3 FY26, reaching Rs 9,633 million, largely driven by the integration of newly acquired businesses. EBITDA saw an even more significant jump of 312.2% to Rs 610 million, reflecting improved operational efficiency and margin expansion in brands like RiteBite. The company maintained dominant market leadership in key categories, including Sugar Free with a 96.3% share and Glucon-D with a 59% share. Furthermore, the expansion of the 'WeightWorld' brand into European markets like Poland and Finland signals a strong international growth strategy.
Key Highlights
Net Sales grew by 113.7% y-o-y to Rs 9,633 million, while EBITDA rose 312.2% to Rs 610 million.
Sugar Free maintained a dominant 96.3% market share, gaining 80 basis points year-on-year.
RiteBite Max Protein margins improved from breakeven a year ago to near double-digit levels.
Glucon-D and Nycil retained leadership positions with 59% and 33.1% market shares respectively.
International expansion continued with Comfort Click entering Poland, Finland, and Portugal.
💼 Action for Investors
Investors should view the strong sales and EBITDA growth as a sign of successful acquisition integration and brand strength. Monitor the sustainability of margins in the newly acquired segments and the performance of international expansions.
Zydus Wellness Q3 FY26 Net Sales Surge 113.7% to ₹963 Cr; Gross Margins Expand 1561 bps
Zydus Wellness reported a massive 113.7% YoY increase in net sales to ₹963.3 crore for Q3 FY26, primarily driven by the integration of Comfort Click and strong momentum in the RiteBite Max Protein business. Gross margins saw a significant expansion of 1561 bps to 63.3%, aided by a favorable product mix and newly acquired international brands. Despite the top-line surge, the company reported a PAT loss of ₹39.9 crore for the quarter, compared to a profit of ₹6.4 crore in the previous year, reflecting acquisition-related impacts. Core brands like Sugar Free and Everyuth maintained dominant market leadership with 96.3% and 48.5% shares respectively.
Key Highlights
Net Sales for Q3 FY26 grew by 113.7% YoY to ₹9,633 million, while YTD FY26 sales rose 38.4% to ₹24,639 million.
Gross Margin expanded significantly by 1561 bps YoY to 63.3% in Q3 FY26, driven by premiumization and the Alidac UK acquisition.
RiteBite Max Protein business doubled its legacy performance and achieved nearing double-digit EBITDA margins post-integration.
Sugar Free maintains a dominant 96.3% market share, while Everyuth Scrub holds 48.5% of its category.
International business expanded into Poland, Finland, and Portugal through the WeightWorld brand under Comfort Click.
💼 Action for Investors
Investors should monitor the company's ability to translate high top-line growth and expanded gross margins into bottom-line profitability as acquisition costs stabilize. The strong market share in core categories provides a defensive moat, but the impact of seasonal brands like Glucon-D and Nycil remains a key variable for upcoming quarters.
Zydus Wellness Q3 Standalone Revenue Jumps 53% to ₹1,526 Million; Net Profit at ₹121 Million
Zydus Wellness reported a robust 53% year-on-year growth in standalone revenue for Q3 FY26, reaching ₹1,526 million. However, standalone net profit remained nearly flat at ₹121 million compared to ₹118 million in the previous year, primarily due to higher material costs and exceptional items. The company recognized a ₹15 million one-time charge related to the New Labour Codes and completed the consolidation of Naturell (India) Private Limited. Investors should note a significant net loss of ₹1,062 million reported by a key subsidiary in the consolidated results, which may weigh on overall group performance.
Key Highlights
Standalone Revenue from operations increased 53% YoY to ₹1,526 million from ₹997 million.
Standalone Net Profit stood at ₹121 million, showing a marginal 2.5% growth YoY.
Exceptional items include ₹15 million for New Labour Code compliance and ₹97 million related to Naturell India liquidation.
A major subsidiary reported a significant net loss of ₹1,062 million for the quarter ended December 31, 2025.
Equity shares were successfully sub-divided from a face value of ₹10 to ₹2 effective September 19, 2025.
💼 Action for Investors
While standalone revenue growth is impressive, investors should exercise caution due to the substantial losses reported in the consolidated subsidiary. Monitor the management's commentary on the turnaround of subsidiary operations and the margin pressure from rising material costs.
Zydus Wellness Gets Interim Relief from Gujarat HC on ₹56.33 Crore GST Demand
Zydus Wellness's subsidiary, ZWPL, has secured ad-interim relief from the Gujarat High Court regarding a GST demand of ₹56.33 crores plus interest and penalties. The court has restrained further proceedings related to the Order-in-Original dated September 30, 2025. Crucially, the company stated that the tax liability pertains to the period before January 30, 2019, which is prior to the acquisition. This liability is fully indemnified by Heinz Italia S.P.A., meaning there is no direct financial impact on Zydus Wellness.
Key Highlights
Gujarat High Court granted ad-interim relief restraining proceedings for a ₹56.33 crore GST demand.
The demand was issued by the DGGI, Surat Zonal Unit, under Section 74(5) of the CGST Act.
The tax dispute relates to the pre-acquisition period prior to January 30, 2019.
Liability is fully indemnified by Heinz Italia S.P.A., protecting the company's balance sheet.
The writ petition was filed under Article 226 of the Constitution of India challenging the OIO.
💼 Action for Investors
Investors should take comfort in the fact that the liability is indemnified by the previous owner, Heinz, and the court has stayed the proceedings. No immediate negative impact on the company's financials is expected.